Even before the success of HBO's Elizabeth Holmes, Theranos casts a long shadow over healthcare startups



[ad_1]

<div _ngcontent-c14 = "" innerhtml = "

Fraud Theranos

REPORT – In this November 2, 2015 photo, Elizabeth Holmes, Founder and Executive Director of Theranos, speaks at the Fortune Global Forum in San Francisco. On Wednesday, March 14, 2018, the Securities and Exchange Commission filed a complaint against Holmes and hisASSOCIATED PRESS

On Monday, Alex Gibney's documentary about Elizabeth Holmes and her blood test company, Theranos, will be air on HBO. Previous Gibney documentary topics include Enron and Scientology.

"The Inventor: Out for Blood in Silicon Valley" describes how Holmes retired from Stanford, founded Theranos to make blood tests more accessible, mobilized enough capital to give the company a value of $ 9 billion and was dissolved once John Carreyrou of the the Wall Street newspaper started reporting problems related to the company's blood test devices.

Theranos and Holmes have become a new point of reference in the discussion of Silicon Valley start-ups attempting to hack health care. For a time, Theranos had not published any peer-reviewed studies on its technology, a warning sign for scientists. Health startups are still do not publish a lot of peer reviewed research, but the industry now has to rely with the example of Theranos.

Holmes certainly had the personal charisma to deal with skeptics. Like a Forbes Matthew Herper, a journalist, doubted the company and asked tough questions to interview him on stage at the Forbes Under 30 summit of 2015. But after the interview, he left, "fantasizing briefly about what would be working in Theranos, something I never did after interviewing a CEO of biotechnology, "he said. written last year.

Before his fall, Holmes was briefly on top of Forbes"The list of the most affluent women with a net worth of $ 4.5 billion, based on its 50% stake in Theranos. Just next year Forbes reduce its net worth to zero, after Carreyrou's report made it clear that the company's products fell short of its demands.

The whistleblower Theranos Tyler Shultz, on the scene at Forbes"Under-30 Summit of 2017," said that after starting to work for the company, it became clear that "everyone knew somehow that this business was not at the height of what we claimed ".

"Holmes" is extremely convincing, it really makes you feel that she cares so much about you, helping the world, "says Shultz," selling her vision all the time. "

">

Fraud Theranos

REPORT – In this November 2, 2015 photo, Elizabeth Holmes, Founder and Executive Director of Theranos, speaks at the Fortune Global Forum in San Francisco. On Wednesday, March 14, 2018, the Securities and Exchange Commission filed a complaint against Holmes and hisASSOCIATED PRESS

On Monday, Alex Gibney's documentary about Elizabeth Holmes and her blood test company, Theranos, will air on HBO. Previous Gibney documentary topics include Enron and Scientology.

"The Inventor: Out for Blood in Silicon Valley" describes how Holmes abandoned Stanford, founded Theranos to make blood tests more accessible, mobilized enough capital to give the company $ 9 billion worth once John Carreyrou of the Wall Street newspaper started reporting problems related to the company's blood test devices.

Theranos and Holmes have become a new point of reference in the discussion of Silicon Valley startups trying to hack health care. For a time, Theranos had not published any peer-reviewed studies on its technology, a warning sign for scientists. Startups in the health sector still do not publish much peer-reviewed research, but the industry now has to rely on the example of Theranos.

Holmes certainly had the personal charisma to deal with skeptics. Like a Forbes Matthew Herper, a journalist, doubted the company and asked tough questions to interview him on stage at the Forbes Under 30 summit in 2015. But after the interview, he left, "fantasizing briefly about what would be working in Theranos, something I never did after interviewing a CEO of biotechnology, "he wrote last year.

Before his fall, Holmes was briefly on top of Forbes"The list of the most affluent women with a net worth of $ 4.5 billion, based on its 50% stake in Theranos. Just next year Forbes reduced its net worth to zero, after Carreyrou's report had shown that the company's products fell short of its claims.

The whistleblower Theranos Tyler Shultz, on stage at Forbes"Under-30 Summit of 2017," said that after starting to work for the company, it became clear that "everyone knew somehow that this business was not at the height of what we claimed ".

"[Holmes] is extremely convincing, really gives you the impression that she cares so much about you, helping the world, "said Shultz," selling his vision all the time. "

[ad_2]

Source link